It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Dynamic mapping of extracellular pH (pHe) at the single-cell level is critical for understanding the role of H+ in cellular and subcellular processes, with particular importance in cancer. While several pHe sensing techniques have been developed, accessing this information at the single-cell level requires improvement in sensitivity, spatial and temporal resolution. We report on a zwitterionic label-free pH nanoprobe that addresses these long-standing challenges. The probe has a sensitivity > 0.01 units, 2 ms response time, and 50 nm spatial resolution. The platform was integrated into a double-barrel nanoprobe combining pH sensing with feedback-controlled distance dependance via Scanning Ion Conductance Microscopy. This allows for the simultaneous 3D topographical imaging and pHe monitoring of living cancer cells. These classes of nanoprobes were used for real-time high spatiotemporal resolution pHe mapping at the subcellular level and revealed tumour heterogeneity of the peri-cellular environments of melanoma and breast cancer cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Department of Medicine, Imperial College London, London, UK; Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China
2 Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa, Japan; Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST), Saitama, Japan
3 Department of Surgery and Cancer, Imperial College London, London, UK
4 Department of Earth Science & Engineering, Imperial College London, London, UK
5 Department of Medicine, Imperial College London, London, UK
6 Cell Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George’s, University of London, London, UK
7 Department of Medicine, Imperial College London, London, UK; National University of Science and Technology “MISIS”, Moscow, Russian Federation
8 Department of Pharmaceutical Physiology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
9 Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa, Japan
10 National University of Science and Technology “MISIS”, Moscow, Russian Federation; Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
11 National University of Science and Technology “MISIS”, Moscow, Russian Federation
12 Department of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
13 Department of Chemistry, Imperial College London, London, UK
14 Department of Chemistry, University of Cambridge, London, UK
15 Department of Medicine, Imperial College London, London, UK; Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa, Japan